cH36
Phase 1- Indications
- Acute lung injury
Company intelligence / Profile preview
Sunol Molecular Corporation
Miramar, Florida, United Statessbir.gov ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Phase 1
01
Overview
Sunol Molecular developed novel gel therapeutics and biologic drugs targeting human tissue factor for thrombosis, single-chain T cell receptor immunoconjugates for cancer therapy, and monoclonal antibodies against Shiga toxins for bacterial infections. Its lead programs included an anti-tissue factor antibody that showed efficacy in preclinical primate models and an anti-Shiga toxin mAb that reached Phase 2 trials in South America before being discontinued. The company was acquired by Altor BioScience in 2005, which itself became part of ImmunityBio.
- Therapeutic areas
- Infectious DiseasesOncologyHematology
- Modalities
- Monoclonal antibodies (mAbs)Single-chain T cell receptors (scTCRs)
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Sunol Molecular Corporation.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sunol Molecular Corporation.